Tonix is a biopharmaceutical company, publicly traded on NASDAQ (ticker: TNXP). The Company is focused on commercializing, developing, discovering and licensing therapeutics to treat and prevent human disease. Tonix markets Zembrace® SymTouch® (sumatriptan injection) 3 mg and Tosymra® (sumatriptan nasal spray) 10 mg. Zembrace SymTouch and Tosymra are each indicated for the treatment of acute migraine with or without aura in adults. Tonix’s development portfolio is composed of central nervous system (CNS), rare disease, immunology and infectious disease product candidates. Tonix’s CNS development portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. The Company’s immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer. Tonix’s infectious disease pipeline consists of a vaccine in development to prevent smallpox and monkeypox, which also serves as the live virus vaccine platform or recombinant pox vaccine platform for other infectious diseases.
View Top Employees from Tonix PharmaceuticalsWebsite | http://www.tonixpharma.com |
Ticker | TNXP |
Revenue | $5 million |
Funding | $710000 |
Employees | 108 (103 on RocketReach) |
Founded | 2007 |
Address | 26 Main St Suite 101, Chatham, New Jersey 07928, US |
Phone | (212) 980-9155 |
Fax | (212) 923-5700 |
Technologies |
JavaScript,
HTML,
Google Analytics
+16 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Medical, Health Care, Pharmaceutical |
Web Rank | 5 Million |
Keywords | Innovative Drug Development, Immunology |
Competitors | AGY Therapeutics, Inc., Embera NeuroTherapeutics, Nephrogenex, NeurOp, Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Tonix Pharmaceuticals employee's phone or email?
The Tonix Pharmaceuticals annual revenue was $5 million in 2024.
Bradley Saenger is the CFO of Tonix Pharmaceuticals.
103 people are employed at Tonix Pharmaceuticals.
Tonix Pharmaceuticals is based in Chatham, New Jersey.
The NAICS codes for Tonix Pharmaceuticals are [3254, 32541, 325, 32].
The SIC codes for Tonix Pharmaceuticals are [28, 283].